HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Functional alterations of the microflora in patients with ulcerative colitis.

Abstract
The aim of the study was to examine microflora-associated characteristics in patients with inactive ulcerative colitis, receiving sulphasalazine, in relation to the spread of the disease. The conversion of cholesterol to coprostanol, the production of urobilinogen, and the degradation of tryptic activity (FTA) and beta-aspartylglycine were measured in faecal samples from patients with proctitis or left-sided or total ulcerative colitis and in age- and sex-matched controls. No significant differences in the results were observed in patients with various degrees of extension of inflammatory bowel disease. However, the coprostanol ratio and the urobilinogen level were lower and the FTA was higher in patients with colitis than in the controls (p < 0.05). Beta-aspartylglycine was not found in any faecal sample. The results indicate that patients with ulcerative colitis taking sulphasalazine have a microflora with abnormal metabolic characteristics.
AuthorsP Benno, C E Leijonmarck, U Monsén, A Uribe, T Midtvedt
JournalScandinavian journal of gastroenterology (Scand J Gastroenterol) Vol. 28 Issue 9 Pg. 839-44 (Sep 1993) ISSN: 0036-5521 [Print] England
PMID7901893 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Dipeptides
  • Urobilinogen
  • aspartylglycine
  • Sulfasalazine
  • Cholestanol
  • Cholesterol
  • Trypsin
Topics
  • Adult
  • Cholestanol (analysis)
  • Cholesterol (metabolism)
  • Colitis, Ulcerative (drug therapy, microbiology)
  • Dipeptides (metabolism)
  • Feces (chemistry)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Proctitis (microbiology)
  • Sulfasalazine (therapeutic use)
  • Trypsin (metabolism)
  • Urobilinogen (biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: